StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Earnings

Pharma-Bio Serv's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 28, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$2.30M
+15.0% on a year earlier
EPS, Q3 FY2026
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Pharma-Bio Serv's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Oct 31, 2026Jan 28, 2027Expected––––
Q3 FY2026ended Jul 31, 2026Sep 14, 2026during market hours$2.30M+15.0%–Release
Q2 FY2026ended Apr 30, 2026Jun 15, 2026during market hours$2.70M+12.5%–Release
Q1 FY2026ended Jan 31, 2026Mar 17, 2026during market hours$2.30M-8.0%–Release
Q4 FY2025ended Oct 31, 2025Jan 29, 2026during market hours–––Release
Q3 FY2025ended Jul 31, 2025Sep 15, 2025during market hours$2.00M––Release
Q2 FY2025ended Apr 30, 2025Jun 16, 2025during market hours$2.40M––Release
Q1 FY2025ended Jan 31, 2025Mar 17, 2025during market hours$2.50M––Release
Q4 FY2024ended Oct 31, 2024Jan 29, 2025during market hours–––Release
Q3 FY2024ended Jul 31, 2024Sep 16, 2024during market hours–––Release
Q2 FY2024ended Apr 30, 2024Jun 14, 2024during market hours–––Release
Q1 FY2024ended Jan 31, 2024Mar 18, 2024during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Pharma-Bio Serv has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Pharma-Bio Serv puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Pharma-Bio Serv filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. News
  10. Results
  11. Results
  12. Results
  13. Results
  14. News
  15. Results

See a number that looks wrong?